Catecholamines, adiponectin, and insulin resistance as measured by HOMA in children with obstructive sleep apnea

Sleep

Volumn 33, Issue 9, 2010, Pages 1185-1191

  Kelly, Andrea ^a,b   Dougherty, Shayne ^a   Cucchiara, Andrew ^b   Marcus, Carole L ^a,b   Brooks, Lee J ^a,b  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Adiponectin; Insulin resistance; Obstructive sleep apnea; Pediatrics

Indexed keywords

ADIPONECTIN; CATECHOLAMINE DERIVATIVE; GLUCOSE; INSULIN; NORADRENALIN; NORMETADRENALIN;

ADOLESCENT; ANALYTIC METHOD; ARTICLE; BODY MASS; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTATIC MODEL OF INSULIN RESISTANCE; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; MALE; OBESITY; POLYSOMNOGRAPHY; PREPUBERTY; PRESCHOOL CHILD; PRIORITY JOURNAL; PUBERTY; SCHOOL CHILD; SLEEP APNEA SYNDROME;

EID: 77956354040     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.1093/sleep/33.9.1185     Document Type: Article

References (65)

1. Alberti K, Zimmet P. Definition, diagnosis and classification of diabetes mellitus and its complications: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
2. Elmasry A, Lindberg E, Berne C, et al. Sleep-disordered breathing and glucose metabolism in hypertensive men: a population-based study. J Intern Med 2001;249:153-61.
3. Lakka H, Laaksonen D, Lakka T, et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 2002;288:2709-16.
4. Ford E, Giles W, Dietz W. Prevalence of the metabolic syndrome among US adults: findings from the Third National Health and Nutrition Examination Survey. JAMA 2002;287:356-9.
5. Cali AM, Caprio S. Obesity in children and adolescents. J Clin Endocrinol Metab 2008;93:S31-6.
6. Bixler EO, Vgontzas AN, Lin HM, et al. Sleep disordered breathing in children in a general population sample: prevalence and risk factors. Sleep 2009;32:731-6.
7. Kohler MJ, Thormaehlen S, Kennedy JD, et al. Differences in the association between obesity and obstructive sleep apnea among children and adolescents. J Clin Sleep Med 2009;5:506-11.
8. Carlson J, Hedner J, Ejnell H, Peterson L. High prevalence of hypertension in sleep apnea patients independent of obesity. Am J Respir Crit Care Med 1994;150:72-7.
9. Ip M, Lam B, Ng M, Lam W, Tsang K, Lam L. Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 2002;165:670-76.
10. Punjabi N, Sorkin J, Katzel L, Goldberg A, Schwartz A, Smith P. Sleep-disordered breathing and insulin resistance in middle-aged and over-weight men. Am J Respir Crit Care Med 2002;165:677-82.
11. Young T, Peppard P, Gottlieb D. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med 2002;165:1217-39. (Pubitemid 34461732)
12. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetes. Arterioscler Thromb Vasc Biol 2000;20:1595-99.
13. Hara K, Boutin P, Mori Y, et al. Genetic variation in the gene encoding adiponection is associated with an increased risk of type 2 diabetes in the Japanese population. Diabetes 2002;51:536-40.
14. Kondo H, Shimomura I, Matsukawa Y, et al. Association of adiponection mutation with type 2 diabetes. Diabetes 2002;51:2325-2328.
15. Menzaghi C, Ercolino T, DiPaolo E, et al. A haplotype at the adiponectin locus is associated with obesity and other features of the insulin resistance syndrome. Diabetes 2002;51:2306-12. (Pubitemid 34729040)
16. Stumvoll M, Tschritter O, Fritsche A, et al. Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity. Interaction with family history of type 2 diabetes. Diabetes 2002;51:37-41.
17. Delporte M, Funahahi T, Takahashi M, Matsuzawa Y, Brichard S. Pre- and post-translational negative effect of B-adrenoceptor agonists on adiponectin secretion: in vitro and in vivo studies. Biochem J 2002;367:677-85. (Pubitemid 35305706)
18. Zhang XL, Yin KS, Li C, Jia EZ, Li YQ, Gao ZF. Effect of continuous positive airway pressure treatment on serum adiponectin level and mean arterial pressure in male patients with obstructive sleep apnea syndrome. Chin Med J (Engl) 2007;120:1477-81. (Pubitemid 47496581)
19. West SD, Nicoll DJ, Wallace TM, Matthews DR, Stradling JR. Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes. Thorax 2007;62:969-74.
20. Sharma SK, Kumpawat S, Goel A, Banga A, Ramakrishnan L, Chaturvedi P. Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 2007;8:12-7. (Pubitemid 46044133)
21. Masserini B, Morpurgo PS, Donadio F, et al. Reduced levels of adiponectin in sleep apnea syndrome. J Endocrinol Invest 2006;29:700-5. (Pubitemid 44756174)
22. Makino S, Handa H, Suzukawa K, et al.Obstructive sleep apnoea syndrome, plasma adiponectin levels, and insulin resistance. Clin Endocrinol (Oxf) 2006;64:12-9.
23. Zhang XL, Yin KS, Wang H, Su S. Serum adiponectin levels in adult male patients with obstructive sleep apnea hypopnea syndrome. Respiration 2006;73:73-7.
24. delaEva R, Baur L, Donaghue K, Waters K. Metabolic correlates with obstructive sleep apnea in obese subjects. J Pediatr 2002;140:641-3.
25. Marcus C, Greene M, Carroll J. Blood pressure in children with obstructive sleep apnea. Am J Respir Crit Care Med 1998;157:1098-103.
26. Tauman R, O'Brien LM, Ivanenko A, Gozal D. Obesity rather than severity of sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 2005;116:e66-73.
27. Amin RS, Carroll JL, Jeffries JL, et al. Twenty-four-hour ambulatory blood pressure in children with sleep-disordered breathing. Am J Respir Crit Care Med 2004;169:950-6.
28. Tauman R, Serpero LD, Capdevila OS, et al. Adipokines in children with sleep disordered breathing. Sleep 2007;30:443-9.
29. Moran A, Jacobs DR Jr, Steinberger J, et al. Insulin resistance during puberty: results from clamp studies in 357 children. Diabetes 1999;48:2039-44.
30. Deckelbaum R, Williams C. Childhood obesity: the health issue. Obes Rev 2001;9:239S-243S.
31. Ogden C, Flegal K, Carroll M, Johnson C. Prevalence and trends in overweight among US children and adolescents, 1999-2000. JAMA 2002;288:1728-32.
32. Steinberger J, Moran A, Hong CP, Jacobs DR Jr, Sinaiko AR. Adiposity in childhood predicts obesity and insulin resistance in young adulthood. J Pediatr 2001;138:469-73.
33. Ogden CL, Kuczmarski RJ, Flegal KM, et al. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics 2002;109:45-60.
34. Morris N, Udry J. Validation of a self-administered instrument to assess stage of adolescent development. J Youth Adolesc 1980;9:271-80. (Pubitemid 11247388)
35. Schall J, Semeao E, Stallings V, Zemel B. Self-assessment of sexual maturity status in children with Crohn's disease. J Pediatr 2002;141:223-9.
36. Tanner J. Growth at Adolescence. Oxford, United Kingdom: Blackwell Scientific Publications; 1962.
37. Iber C, ed. The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specification. Westchester, IL: American Academy of Sleep Medicine; 2007.
38. Witmans MB, Keens TG, Davidson Ward SL, Marcus CL. Obstructive hypopneas in children and adolescents: normal values. Am J Respir Crit Care Med 2003;168:1540.
39. Traeger N, Schultz B, Pollock AN, Mason T, Marcus CL, Arens R. Polysomnographic values in children 2-9 years old: additional data and review of the literature. Pediatr Pulmonol 2005;40:22-30. (Pubitemid 40917904)
40. Uliel S, Tauman R, Greenfeld M, Sivan Y. Normal polysomnographic respiratory values in children and adolescents. Chest 2004;125:872-8. (Pubitemid 38367276)
41. Salloum A, Rowley JA, Mateika JH, Chowdhuri S, Omran Q, Badr MS. Increased propensity for central apnea in patients with obstructive sleep apnea: effect of nasal continuous positive airway pressure. Am J Respir Crit Care Med 2010;181:189-93.
42. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
43. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006;29:2427-32.
44. Schechter MS. Technical report: diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics 2002;109:e69.
45. Pussard E, Neveux M, Guigueno N. Reference intervals for urinary catecholamines and metabolites from birth to adulthood. Clin Biochem 2009;42:536-9.
46. Bottner A, Kratzsch J, Muller G, et al. Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels. J Clin Endocrinol Metab 2004;89:4053-61. (Pubitemid 39071513)
47. Snow AB, Khalyfa A, Serpero LD, et al. Catecholamine alterations in pediatric obstructive sleep apnea: effect of obesity. Pediatr Pulmonol 2009;44:559-67.
48. Kaditis AG, Alexopoulos EI, Damani E, et al. Urine levels of catecholamines in Greek children with obstructive sleep-disordered breathing. Pediatr Pulmonol 2009;44:38-45.
49. Marrone O, Riccobono L, Salvaggio A, Mirabella A, Bonanno A, Bonsignore MR. Catecholamines and blood pressure in obstructive sleep apnea syndrome. Chest 1993;103:722-7. (Pubitemid 23086163)
50. Fletcher EC, Miller J, Schaaf JW, Fletcher JG. Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 1987;10:35-44.
51. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Adiponectin gene expression is inhibited by beta-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett 2001;507:142-6. (Pubitemid 33001531)
52. Schulpis KH, Papassotiriou I, Tsakiris S, Vounatsou M, Chrousos GP. Increased plasma adiponectin concentrations in poorly controlled patients with phenylketonuria normalize with a strict diet: evidence for catecholamine- mediated adiponectin regulation and a complex effect of phenylketonuria diet on atherogenesis risk factors. Metabolism 2005;54:1350-5.
53. Fu L, Isobe K, Zeng Q, Suzukawa K, Takekoshi K, Kawakami Y. beta-adrenoceptor agonists downregulate adiponectin, but upregulate adiponectin receptor 2 and tumor necrosis factor-alpha expression in adipocytes. Eur J Pharmacol 2007;569:155-62.
54. Wellen K, Hotamisligil G. Obesity-induced inflammatory changes in adipose tissue. J Clin Invest 2003;112:1785-8. (Pubitemid 38063699)
55. Field AE, Laird N, Steinberg E, Fallon E, Semega-Janneh M, Yanovski JA. Which metric of relative weight best captures body fatness in children? Obes Res 2003;11:1345-52.
56. Gozal D, Capdevila OS, Kheirandish-Gozal L. Metabolic alterations and systemic inflammation in obstructive sleep apnea among nonobese and obese prepubertal children. Am J Respir Crit Care Med 2008;177:1142-9. (Pubitemid 351717574)
57. Oh DK, Ciaraldi T, Henry RR. Adiponectin in health and disease. Diabetes Obes Metab 2007;9:282-9.
58. Heidemann C, Sun Q, van Dam RM, et al. Total and high-molecular-weight adiponectin and resistin in relation to the risk for type 2 diabetes in women. Ann Intern Med 2008;149:307-16.
59. Department of Health, Education and Welfare, National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. Research Involving Children Report and Recommendation. In. Washington, DC: Department of Health, Education and Welfare; 1977:(Publication no. [OS] 77-0004).
60. Code of Federal Regulations. 45 CFR 46:401-409. Additional protections for children involved as subjects in research. (Subpart D: US Department of Health and Human Services. In. Fed Reg; 1983:9816-9820.
61. Kopelman LM, Murphy TF. Ethical concerns about federal approval of risky pediatric studies. Pediatrics 2004;113:1783-9.
62. Gungor N, Saad R, Janosky J, Arslanian S. Validation of surrogate estimates of insulin sensitivity and insulin secretion in children and adolescents. J Pediatr 2004;144:47-55. (Pubitemid 38091421)
63. Gottlieb DJ, Punjabi NM, Newman AB, et al. Association of sleep time with diabetes mellitus and impaired glucose tolerance. Arch Intern Med 2005;165:863-7.
64. Ayas NT, White DP, Manson JE, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med 2003;163:205-9.
65. Donga E, van Dijk M, van Dijk JG, et al. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 2010;95:2963-8.